ALNYLAM PHARMACEUTICALS, INC. Underwriting Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated January 14, 2019, between Alnylam Pharmaceuticals, Inc. and Barclays Capital Inc
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2019
Underwriting Agreement, dated November 13, 2017, by and among Alnylam Pharmaceuticals, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives of the...
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2017
ALNYLAMPHARMACEUTICALS, INC. 5,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2017
ALNYLAMPHARMACEUTICALS, INC. 4,736,842 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2015
ALNYLAM PHARMACEUTICALS, INC. 8,000,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2013
ALNYLAM PHARMACEUTICALS, INC. 7,500,000 Shares of Common Stock Underwriting Agreement
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2012
EX-1.1 Underwriting Agreement, dated December 12, 2006
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
MA
2006
EX-1.1 Amendment to Underwriting Agreement
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
2004
EX-1.1 UNDERWRITING AGREEMENT
Underwriting Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2004